In the ATTAIN-1 trial, adverse events led to treatment discontinuation in up to 10.3 percent of patients on the drug, compared to only 2.7 percent on placebo
2023 Apr;112:154716
Adding the GLP-1 prescription to the computer screen as hospital issue is therefore sensible, as this will pick up possible interactions
It supports the protection and regeneration of the digestive lining, aiding recovery from damage caused by ulcers, inflammation, or injury
Men with underlying cardiovascular issues must approach this therapy cautiously, and all users should be aware of the dos and donts (no more than one dose per 24 hours, etc.) to use it safely.When used correctly, the safety data is reassuring: side effects are generally transient and manageable, with transient blood pressure increasesbeing the main concern to monitorfda.gov
Metastatic hepatocellular carcinoma